BLT 0.00% 2.6¢ benitec biopharma limited

Dr. Peter French Reply to Dr. KSS Article on Benitec., page-29

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    Apparently karmaswimswami or KSS did not like my criticism of his post on Gumshoe, which was repeated here on HC and to which I replied. Seems I really got up his nose. Bad luck is all I can say.

    His ego has gotten so big that his head has no room for memory because I am told that he now refutes ever saying that he claimed that TT-034 patients had been dosed in January 2014.

    Well here is a little memory jogger:

    January 10 2014 He said on Gumshoe,

    "This month, 14 patients at both UCSD and Duke with genotype 1 HCV that have failed customary antiviral treatment will be dosed with TT-034."

    January 30 2014 He said,

    "Benitec’s first TT-034 patients have already been dosed. 28 days afer that first dose, the protocol calls for them to have repeat HCV RNA by RT-PCR done." (courtesy of Buda's post here on HC)

    Seem someone is either waiting for a ddRNAi treatment for Alzheimer's or they are telling pork pies. Either way KSS, credibility zero.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.